BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9776816)

  • 21. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole.
    Chryssanthou E
    Scand J Infect Dis; 1997; 29(5):509-12. PubMed ID: 9435042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
    Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole.
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW;
    Clin Microbiol Infect; 2012 Jul; 18(7):E248-50. PubMed ID: 22540149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions.
    Meletiadis J; te Dorsthorst DT; Verweij PE
    Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption.
    Araujo R; Coutinho I; Espinel-Ingroff A
    J Antimicrob Chemother; 2008 Dec; 62(6):1277-80. PubMed ID: 18824456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
    Chryssanthou E; Loebig A; Sjölin J
    J Antimicrob Chemother; 2008 Jun; 61(6):1309-11. PubMed ID: 18367461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus.
    Shekhova E; Kniemeyer O; Brakhage AA
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis RE; Wiederhold NP; Klepser ME
    Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired itraconazole resistance in Aspergillus fumigatus.
    Dannaoui E; Borel E; Monier MF; Piens MA; Picot S; Persat F
    J Antimicrob Chemother; 2001 Mar; 47(3):333-40. PubMed ID: 11222566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus.
    Dannaoui E; Borel E; Persat F; Monier MF; Piens MA; Network E
    J Med Microbiol; 1999 Dec; 48(12):1087-1093. PubMed ID: 10591162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of Aspergillus strains from culture collections to amphotericin B and itraconazole.
    Rath PM
    J Antimicrob Chemother; 1998 May; 41(5):567-70. PubMed ID: 9630411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
    Balajee SA; Imhof A; Gribskov JL; Marr KA
    J Antimicrob Chemother; 2005 Jan; 55(1):102-5. PubMed ID: 15546970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
    Chryssanthou E; Sjölin J
    J Antimicrob Chemother; 2004 Nov; 54(5):940-3. PubMed ID: 15471994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent.
    Manavathu EK; Vazquez JA; Chandrasekar PH
    Int J Antimicrob Agents; 1999 Aug; 12(3):213-9. PubMed ID: 10461839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
    Krishnan S; Manavathu EK; Chandrasekar PH
    J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus.
    Garrigues JC; Cadet de Fontenay G; Linas MD; Lagente M; Seguela JP
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2857-62. PubMed ID: 7695274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.